Hemoperfusion
Governs coverage stance for hemoperfusion (use of ultrafiltration to remove toxins) for CareFirst members; affects providers seeking coverage for hemoperfusion treatments.
No material clinical or coverage changes in this revision.
Coverage Criteria
Medically Necessary Indications
Covered when used for life‑threatening conditions as specified
See Policy Guidelines for typical number of treatments (generally one to five). Procedure may be repeated if a second crisis occurs.
This policy was archived on 3/27/2000. As stated in the archived notice, the application of this policy is no longer limited by the diagnoses listed in the policy. Providers should note the archival status when considering historical guidance; benefit determination for current claims will depend on the member's contract and applicable coverage rules rather than restriction to the diagnoses originally listed in this policy.
When hemoperfusion is performed for diagnoses other than life‑threatening drug overdose or acute liver failure, the procedure requires review for medical necessity and may be considered not medically necessary if unsupported. Prior review is recommended to avoid claim denial.
Provider Actions & Authorization
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.